Clinicopathological significance of Epo, EpoR, Ki-67 and Bax expression in colorectal cancer

• Authors: Lopmerta, K , Grudzinska, M , Jakubowska, K , Samocik, P , Kozlowski, L , Fudala, A , Wincewicz, A , Koda, M

Abstracts

EN

Introduction: Expression of Epo, a glycoprotein secreted by the fetal liver and the adult kidney in response to cellular hypoxia and its receptor have been described in human solid tumors, such as colon and breast cancer. Purpose: Since activation of Epo-EpoR signaling pathway in erythroid progenitor and precursor cells leads to promotion of proliferation and differentiation or prevention of programmed cell death through Bcl-xl and Bcl-2 it was of interest to investigate expression of Epo, EpoR, apoptosis regulator – Bax and marker of proliferating cells - Ki-67 and assess correlation between them, with regard to clinicopathological variables of colorectal cancer. Materials and methods: The correlations between expression of Epo, EpoR, Bax and Ki-67 in colorectal cancer were analyzed in regard to patient age, sex, primary localization, histopathological type, grading, staging and lymph node invasion. Statistical analyses were performed by using the Spearman rank correlation test applying a significance level of p<0,05. Results: Correlation between Bax and EpoR is positive and statistically significant at all groups of patients except group pT1+pT2. Positive correlation between Bax and Epo is statistically significant at following groups of patients: all patients, age  60, age >60, male, female , primary localization in rectum, primary localization in colon, adenocarcinoma, G2, G3. Statistical analysis revealed no significant correlations between expression of neither Ki-67 with Epo nor Ki-67 with EpoR in all groups of patients. Conclusions: Epo seems to be a pleiotropic cytokine, which can exert its biological effect on several cell types, including neoplastic cells. The effect of Epo-EpoR signaling can differ in various cells and conditions.

Keywords

EN

Colon cancer; erythropoietin; erythropoietin receptor

• Publisher: Uniwersytet Medyczny w Białymstoku
• Journal: Progress in Health Sciences
• Year: 2018
• Volume: 8(2)
• Pages: 112-117

Dates

published

2019-01-04

Contributors

author

Lopmerta, K

author

Grudzinska, M

author

Jakubowska, K

author

Samocik, P

author

Kozlowski, L

author

Fudala, A

author

Wincewicz, A

author

Koda, M

Identifiers

DOI

10.5604/01.3001.0012.8330